Toggle navigation
Home
Search
Services
Blog
Contact
About
1/2 Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia (HHT)
McCrae, Keith R.
Cleveland Clinic Lerner, Cleveland, OH, United States
Search 57 grants from Keith McCrae
Search grants from Cleveland Clinic Lerner
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
University of Medicine & Dentistry of NJ
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Identification of complex cellular phenotypes and their interactions in MS lesions
The effect of the microbiome on the development and severity of uveitis
Development of Bimodal Bilingualism
Trauma Informed Child Welfare Systems
The Biology of Perlecan in Cancer and Angiogenesis
Recently added grants:
Stargardt disease with low lipofuscin
Health Information Exchange Utilization and Inter-hospital Transfer Outcomes
Pathological and functional consequences of dimerization-deficient rhodopsin mutations
Forespore engulfment during B. subtilis sporulation
Development and Validation of Quantitative Anterior Segment OCT-based Methods to Evaluate Patients with Primary Angle Closure Disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Cooperative Agreement Phase II (UH3)
Project #
4UH3HL140097-02
Application #
10026357
Study Section
Clinical Trials Review Committee (CLTR)
Program Officer
Kindzelski, Andrei L
Project Start
2020-03-15
Project End
2024-02-29
Budget Start
2020-03-15
Budget End
2021-02-28
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Institution
Name
Cleveland Clinic Lerner
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Comments
Be the first to comment on Keith McCrae's grant